Description:

ODM derived from http://clinicaltrials.gov/show/NCT00502840

Link:
http://clinicaltrials.gov/show/NCT00502840
Keywords:
Versions (2)
  1. 12/10/13 12/10/13 - Martin Dugas
  2. 9/17/21 9/17/21 -
Uploaded on:

December 10, 2013

DOI:
To request one please log in.
License :
Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00502840 Rheumatoid Arthritis

German English
Details

Eligibility

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
age 18 Years to 75 Years
adult patients with rheumatoid arthritis who participated in ML19070, and have completed the week 24 visit
eligible for re-treatment (DAS28 >2.6 after week 24, swollen joint count >=4, tender joint count >=4).
Exclusion Criteria
patients who have withdrawn from treatment in ML19070 pre-week 16
patients with a previous response in DAS28 <0.6 to MabThera after week 16
concurrent treatment with any DMARD except for methotrexate, any TNF alpha inhibitor, or other biologic or investigational agent.
Back to the top of the page

Similar models

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial